Clinical Trials Directory

Trials / Unknown

UnknownNCT05596643

Investigation of Autonomic Dysfunction in Patients With Familial Mediterranean Fever

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Marmara University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Familial Mediterranean Fever (FMF) is the most common inherited autoinflammatory disease affecting 150,000 patients worldwide. Periodic febrile exacerbations, peritonitis, and pleuritis are characteristic disease features. Dysregulation of IL-1β secretion has an important role in the pathophysiology of the disease, and IL-1β also serves as a therapeutic target. Chronic inflammation has been associated with early atherosclerotic and cardiovascular disease in various rheumatic diseases. An increased risk for cardiovascular events associated with disease activity has been described in rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus. In addition, autonomic nervous system dysfunction may contribute to increased cardiovascular risk in patients with inflammatory disease. For example, decreased heart rate variability is an important feature of cardiac autonomic dysfunction and is an isolated risk factor for cardiovascular events. Autonomic dysfunction studies related to FMF have conflicting results. The aim of this study was to determine autonomic dysfunction symptoms and objective findings in patients with FMF; Demographic characteristics, disease characteristics, inflammatory burden, fatigue level, sleep quality, presence of fibromyalgia and their relationship with quality of life were evaluated and compared with healthy controls.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTComposite Autonomic Symptom Score-31Standardized questionnaire to determine the level of autonomic dysfunction
DIAGNOSTIC_TESTr-r interval variability with normal breathingelectrophysiological test to detect parasympathetic dysfunction
DIAGNOSTIC_TESTr-r interval variability with deep breathingelectrophysiological test to detect parasympathetic dysfunction
DIAGNOSTIC_TESTValsalva ratioelectrophysiological test to detect parasympathetic dysfunction
DIAGNOSTIC_TEST30:15 ratioelectrophysiological test to detect parasympathetic dysfunction
DIAGNOSTIC_TESTsympathetic skin responseelectrophysiological test to detect sympathetic dysfunction
DIAGNOSTIC_TESTblood pressure response to standingclinical test to detect sympathetic dysfunction
DIAGNOSTIC_TESTblood pressure response to sustained handgrip testclinical test to detect sympathetic dysfunction
OTHERHospital anxiety and depression scaleStandardized questionnaire to investigate the depression and anxiety
DIAGNOSTIC_TESTFibromyalgia rapid screening toolStandardized questionnaire to determine the presence of fibromyalgia
OTHERFamilial Mediterranean Fever Quality of life scaleStandardized questionnaire to investigate the quality of life in Familial Mediterranean Fever patients
OTHERJenkins Sleep Evaluation ScaleStandardized questionnaire to investigate the sleep quality and disturbance
OTHERThe Fatigue Severity ScaleStandardized questionnaire to investigate the fatigue severity

Timeline

Start date
2022-03-15
Primary completion
2022-10-31
Completion
2022-10-31
First posted
2022-10-27
Last updated
2022-10-27

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05596643. Inclusion in this directory is not an endorsement.